Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen
Status:
Completed
Trial end date:
2019-01-10
Target enrollment:
Participant gender:
Summary
Helicobacter pylori (H. pylori) is a bacterium its infection is regarded the most common
medical condition associated with gastritis1 more over peptic ulcer disease2, gastric
adenocarcinoma3 and lymphoma.4control of H pylori infection is thought to be the solution of
public health problem.5,6 rate of infection is abating in developed world 7 , but this is
slow and people health is challenged, to stop or decrease the new cases is complicated
despite the fact that route of transmission are still unclear .8-10 The only option for
reducing incidence and prevalence is that screening of masses followed by eradication
therapy. A rough estimate propose about 50% of developing country population is affected from
infection than the industrialized country. Infected individual may be asymptomatic or some
time present with gastroduodenal disease. Prevalence of H pylori is different in developing
countries where the adult prevalence reaches up to 80% and in children it is found before the
age of 10 years.